蔚蓝生物(603739) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 reached ¥363,599,708.49, an increase of 8.09% year-over-year[3] - Total profit for the period was ¥55,308,882.14, reflecting a significant increase of 103.70% compared to the same period last year[3] - Net profit attributable to shareholders was ¥35,062,856.99, marking a substantial growth of 205.02% year-over-year[3] - The basic earnings per share for the quarter was ¥0.14, up 180.00% from the previous year[3] - Total operating revenue for the first three quarters of 2025 reached RMB 1,015,793,037.32, an increase of 7.4% compared to RMB 945,618,593.20 in the same period of 2024[15] - The company reported a net profit margin of approximately 6.8% for the first three quarters of 2025, consistent with the previous year's performance[15] - The net profit for the first three quarters of 2025 reached CNY 82,929,836.08, an increase from CNY 61,067,866.90 in the same period of 2024, representing a growth of approximately 35.8%[16] - The company reported a total comprehensive income of CNY 82,710,492.97 for the first three quarters of 2025, up from CNY 61,009,443.78 in 2024, marking an increase of around 35.7%[17] - Basic and diluted earnings per share for the current period were CNY 0.24, compared to CNY 0.16 in the previous year, representing a growth of 50%[17] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥3,041,531,674.91, representing a 2.03% increase from the end of the previous year[4] - Total assets amounted to RMB 3,041,531,674.91 as of September 30, 2025, compared to RMB 2,981,000,556.19 at the end of 2024, showing an increase of 2.0%[13] - Total liabilities were RMB 1,140,329,570.96 as of September 30, 2025, compared to RMB 1,110,984,258.58 at the end of 2024, representing a rise of 2.6%[14] - The company's retained earnings increased to RMB 777,288,145.15 as of September 30, 2025, compared to RMB 740,811,881.65 at the end of 2024, reflecting a growth of 4.9%[14] Cash Flow and Investments - The net cash flow from operating activities for the year-to-date was ¥33,756,771.81, down 46.59% due to increased raw material purchases[8] - The net cash flow from operating activities decreased to CNY 33,756,771.81 in 2025 from CNY 63,201,814.62 in 2024, reflecting a decline of approximately 46.6%[19] - The cash and cash equivalents at the end of the period were CNY 195,920,607.04, down from CNY 261,677,056.56 at the end of the same period last year, a decrease of approximately 25.1%[20] - The company incurred interest expenses of CNY 12,413,825.03, compared to CNY 16,374,941.90 in the previous year, showing a reduction of about 24.0%[16] - The total cash outflow from investing activities was CNY 721,034,075.45, an increase from CNY 684,590,067.62 in the previous year, indicating a rise of approximately 5.3%[20] - The net cash flow from financing activities turned negative at CNY -29,649,907.91, compared to a positive CNY 14,838,094.73 in the previous year, reflecting a significant change in financing strategy[20] Shareholder Information - The company has a total of 17,002 ordinary shareholders as of the reporting period[9] - The largest shareholder, Qingdao Kangdian Industrial Co., Ltd., holds 44.4% of the shares, totaling 112,407,400 shares[9] Operating Costs and Expenses - Total operating costs for the first three quarters of 2025 were RMB 946,888,887.21, up from RMB 881,905,556.31 in 2024, reflecting a year-on-year increase of 7.4%[15] - Research and development expenses increased to RMB 100,238,559.80 in the first three quarters of 2025, compared to RMB 81,303,889.41 in 2024, marking a growth of 23.3%[15] - Accounts receivable increased to RMB 408,070,064.31 as of September 30, 2025, compared to RMB 350,427,097.14 at the end of 2024, indicating a rise of 16.4%[12] - Inventory levels rose to RMB 216,743,499.06 as of September 30, 2025, compared to RMB 188,950,475.37 at the end of 2024, reflecting a growth of 14.7%[12] Non-Recurring Items - Non-recurring gains and losses for the period totaled ¥28,131,632.98, with government subsidies contributing significantly[6] - The company reported other income of CNY 20,752,969.81, an increase from CNY 17,042,774.30 in the previous year, representing a growth of approximately 21.0%[16] - The weighted average return on net assets increased to 2.01%, up 1.34 percentage points from the previous year[3]